| Dr Donald D Weaver, MD | |
|
1612 31st Ave, Gulfport, MS 39501-2750 | |
| (228) 864-8454 | |
| (228) 865-1457 |
| Full Name | Dr Donald D Weaver |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Geriatric Medicine |
| Location | 1612 31st Ave, Gulfport, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255447900 | NPI | - | NPPES |
| 110136321 | Other | MS | RAILROAD MEDICARE |
| 00114891 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | 14403 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald D Weaver, MD 30 S. Clinton St., Suite 7205, Walla Walla, WA 99362-2497 Ph: (509) 522-1358 | Dr Donald D Weaver, MD 1612 31st Ave, Gulfport, MS 39501-2750 Ph: (228) 864-8454 |
News Archive
Responders to the 2001 World Trade Center (WTC) terrorist attacks, who were exposed to caustic dust and toxic pollutants following the 9/11 disaster, suffer from asthma at a rate more than twice that of the general US population, according to new research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).
Compliance 360, a leading provider of Software-as-a-Service (SaaS) solutions for enterprise governance, risk management and compliance (eGRC) announced today that the Compliance 360 Claims Auditor has been licensed for use in over 200 hospitals since it was launched just 8 months ago.
Women with heart disease typically receive less complete surgical revascularization with arterial grafts than men do, but not because of gender bias. Instead, factors such as delayed diagnosis of coronary artery disease (CAD) in women may contribute to the differences in treatment, according to a new study published online today in The Annals of Thoracic Surgery.
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
› Verified 7 days ago
Marcus John Wilson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-868-8345 | |
Daniel Salmeron, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14116 Customs Blvd, Gulfport, MS 39503 Phone: 601-957-6300 | |
Dr. Paulette L. Foster-galbraith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Darran St, Gulfport, MS 39503 Phone: 228-831-1988 Fax: 228-832-3844 | |
Taylor Hairston, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 15190 Community Rd, Gulfport, MS 39503 Phone: 228-220-5200 | |
Candace Worsham, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1924 30th Ave, Gulfport, MS 39501 Phone: 228-863-7117 | |
Mitchell Adam Sanford, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12057 Highway 49 Ste C, Gulfport, MS 39503 Phone: 228-832-9385 Fax: 888-498-3529 |